Industry concerned over hurdles in FDA’s biosimilars manufacturing changes guidance
Regulatory NewsJason Scott
Biologics/ biosimilars/ vaccinesGuidanceManufacturingProduct LifecycleUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsJason ScottBiologics/ biosimilars/ vaccinesGuidanceManufacturingProduct LifecycleUnited StatesUS Food and Drug Administration (FDA)